Civil Society Position on European Commission Proposal for the Introduction of an SPC Manufacturing Waiver

Joint Statement | 6 November, 2018 | Download PDF

As civil society organisations working on access to medicines and public health, we wish to contribute to the ongoing discussions on the European Commission proposal for the introduction of a Supplementary Protection Certificate (SPC) manufacturing waiver.

European health authorities have a duty to establish a framework guaranteeing access to effective,

Regulating Off-label Use of Medicines in Europe

Policy Brief | 10 October, 2018 | Download PDF

What is off-label use?

Off-label refers to the use of an authorised pharmaceutical product outside the terms of its marketing authorisation; therefore, not in accordance with the information in the Summary of Product Characteristics. Off-label occurs when a medicine is used for a therapeutic indication other than that approved by a regulatory authority,

Shocking Disparity Between Insulin Prices and Cost of Production

Press Release | 25 September, 2018 | Download PDF

A study published today (Tuesday 25 September) in BMJ Global Health shows that, in a global market dominated by just three multinational companies, people living with diabetes are paying far more than they should for life-saving insulin.

The paper,

Global Coalition of Health Organisations Announces First-ever International Snakebite Awareness Day

Press Release | 20 September, 2018 | Download PDF

LONDON—A coalition of organisations working on global health and tropical medicine around the world, including Health Action International, is launching the first-ever International Snakebite Awareness Day to raise awareness of the huge, yet mostly unrecognised, global impact of snakebite.

“We know,

Statement on ENVI Committee Report on Health Technology Assessments

Statement | 13 September, 2018 | Download PDF

AMSTERDAM—Following the European Parliament’s ENVI Committee adoption of a legislative report on Health Technology Assessments, Health Action International’s Senior Policy Advisor, Santos Quintano, made this statement:

“Health Action International (HAI) welcomes today’s vote by the ENVI Committee on the Health Technology Assessments (HTA) Report,

Statement to WHO on Roadmap Report on Access to Medicines & Vaccines

Intervention | 10 September, 2018 | Download PDF

Stichting Health Action International (HAI) welcomes the opportunity to contribute to the discussions on the World Health Organization’s (WHO) Roadmap for Access 2019–2023. We note positively the document under discussion here today, and appreciate the efforts of the Secretariat in translating the mandate of Member States in addressing the global shortage of,

Prices and Availability of Locally Produced and Imported Medicines in Kenya

Report | 8 August, 2018 | Download PDF

A survey was undertaken from January to May 2018 to measure and compare the price and availability of locally produced and imported medicines in Kenya. The survey used a methodology developed by Health Action International (HAI), soon to be published by the World Health Organization (WHO).

Joint Letter to WHO Director-General: WHO’s Roadmap on Access to Medicines and Vaccines 2019-2023

Joint Letter | 7 August, 2018 | Download PDF

Health Action International joined  Knowledge Ecology International (KEI), and other civil society organisations, in writing to the Director-General of the World Health Organization (WHO) on the WHO Roadmap on Access to Medicines and Vaccines.

Read the letter.


Snakebite Incidence, Response & Antivenom Supply in Kilifi County, Kenya

30 July, 2018 | Fact Sheet | Download PDF

Snakebite envenoming is one of the most under-researched and neglected tropical diseases in the world. As part of our Snakebite Programme, Health Action International (HAI) is developing an evidence base on snakebite in Kenya, Uganda and Zambia.

Request to ViiV to Urgently Step-up Efforts to Ensure Widespread Access to dolutegravir for Children

Joint Letter | 24 July, 2018 | Download PDF

Health Action International joined  Médecins Sans Frontières Access Campaign, and over 30 other civil society organisations, in calling on ViiV to urgently step-up efforts to ensure widespread access dolutegravir for children.

Read the letter below, or download the PDF.